Skip navigation
Skip navigation

Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in the Li-Fraumeni Syndrome model, Trp53+/- mice

Blackburn, Anneke; Rooke, Melissa; Li, Yiming; Dahlstrom, Jane; Board, Philip G

Description

BACKGROUND: While genetic testing for familial cancer has excelled, the prevention options for those carrying high risk alleles have not. Altered bioenergetics is now acknowledged as a hallmark of cancer, and several very safe drugs are available that can target this phentoype. Dichloroacetate (DCA) inactivates pyruvate dehydrogenase kinase, resulting in activation of pyruvate dehydrogenase, reduced lactic acid production and increased mitochondrial activity. Metformin, a type 2...[Show more]

CollectionsANU Research Publications
Date published: 2014-05-28
Type: Conference poster
URI: http://hdl.handle.net/1885/95618
Source: Cancer & Metabolism
DOI: 10.1186/2049-3002-2-S1-P10

Download

File Description SizeFormat Image
01_Blackburn_Chemoprevention_with_the_2014.pdfPublished Version180.52 kBAdobe PDFThumbnail


Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  20 July 2017/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator